FindTrial
Sign In

The timing of sugammadex administration

Relationship between timing of sugammadex administration and the upper airway obstruction during awakening from anesthesia – A retrospective study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003356
Enrollment
3391
Registered
2018-11-16
Start date
2018-10-11
Completion date
Unknown
Last updated
2021-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Inje University Haeundae Paik Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who had surgery under general anesthesia at Haeundae Paik Hospital and received intravenous sugammadex to reverse rocuronium-induced neuromuscular blockade

Exclusion criteria

Exclusion criteria: 1) Patients whose monitoring parameters were lacking in electronic medical records (for example, BIS, end-tidal volatile anesthetic concentration, MAC) 2) Total intravenous anesthesia 3) Concomitant use of other reversal agents (for example, pyridostigmine) 4) Administration of sugammadex after extubation

Design outcomes

Primary

MeasureTime frame
occurrence and types of complications after extubation—

Secondary

MeasureTime frame
time to extubate from discontinuation of anesthetics—

Countries

Korea, Republic of

Contacts

Public ContactMyoung Jin Ko

Inje University Haeundae Paik Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026